Polyrizon Ltd. Ordinary Shares (PLRZ NASDAQ) stock market data APIs
$1.0356
-0.21(-20.3%)
as of July 15, 2025
Try our APIs with
free plan!
Polyrizon Ltd. Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Prev. Close
1.0356
Open
0.8292
High
1.3196
Low
0.8146
52 wk Range
0.55-1200
Market Cap
4 725 K
Shares Outstanding
4 194 K
EPS
-72.6
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Polyrizon Ltd. Ordinary Shares data using free add-ons & libraries
Get Polyrizon Ltd. Ordinary Shares Fundamental Data
Polyrizon Ltd. Ordinary Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -654 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-11
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Polyrizon Ltd. Ordinary Shares News
New
Polyrizon secures continued Nasdaq listing after panel hearing
RAANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ) has received approval from the Nasdaq Hearings Panel to maintain its listing on the Nasdaq Capital Market, the biotech company announced Tuesday. Accordi...
Polyrizon Retains Nasdaq Listing Following Hearings Panel
Raanana, Israel, July 15, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innov...
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics
Ra’anana, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a biotechnology company developing intranasal drug delivery systems, toda...
Polyrizon Announces Receipt of Nasdaq Delisting Notice
Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innova...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
